from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1861/-

LFCtreatmentdescriptionclass of inhibitor

1.136

Amikacinug/mL Amikacintranslation

1.700

Cap5-10ug/mL Capreomycintranslation

0.781

Rox10-50 ug/mL Roxithromycintranslation

-0.068

SM2-5 ug/mL Streptomycintranslation

1.725

Tet5-10 ug/mL Tetracyclinetranslation

0.344

Rif0.2-5ug/mL Rifampicintranscription

0.734

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.110

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.734

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.661

CPZ10-50 ug/mL Chlorpromazinerespiration

0.428

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.071

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.881

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.079

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.053

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.056

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.481

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.046

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.214

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.012

KCN5-20 ug/mL Potassium cyaniderespiration

-0.202

NaN30.2-2 mM Sodium aziderespiration

-0.186

Nigericin50 uM Nigericinrespiration

1.415

TRC10-150 ug/mL Triclosanrespiration

2.162

TRZ10-25 ug/mL Thioridazinerespiration

-0.845

Valinomycin0.5-10 uM Valinomycinrespiration

-0.643

ZnSO42 mM ZnSO4respiration

-0.002

menadione6-10 ug/mL Menadionerespiration

-0.280

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.706

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.919

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.708

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.518

NRP_1Non-replicating persistence stage 1dosRassociated

-0.335

Amp0.2mg/mL AmpicillincellWall

0.033

Cephalexin20-100 ug/mL CephalexincellWall

-0.058

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.743

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.119

EMB10-20 ug/mL EthambutolcellWall

0.478

Eta12-40 ug/mL EthionamidecellWall

0.452

INH0.2-0.4 ug/mL IsoniazidcellWall

0.320

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.657

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.341

BZA0.12 mg/mL BenzamidearomaticAmides

-0.561

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.557

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.323

H2O24 mM hydrogen peroxideDNAdamaging

0.047

Levo10 ug/mL LevofloxacinDNAdamaging

-0.839

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.699

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.017

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.577

UVUV-irradiationDNAdamaging

0.592

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.797

Antimycin12.5-50 ug/mL Antimycin A?

-0.530

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.074

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.237

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.215

PA8240.2-2 ug/mL PA-824?

-0.099

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.050

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.127

Verapamil50 uM Verapamil?

-0.099

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.700

methoxatin10-20 ug/mL Methoxatin?